58 related articles for article (PubMed ID: 2145846)
1. Dopaminergic activity and stereochemical considerations for rigid angular tricyclic congeners of dopamine: benzoquinoxalines and naphthothiazines.
Perrone R; Berardi F; Tortorella V; Racagni G; Rovescalli A
Farmaco; 1990 May; 45(5):479-88. PubMed ID: 2145846
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
[TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor agonists: new angularly annulated tricyclic compounds.
Perrone R; Berardi F; Bettoni G; Tortorella V
Farmaco Sci; 1988 Jan; 43(1):61-9. PubMed ID: 3396689
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives.
Claudi F; Cingolani GM; Giorgioni G; Cattabeni F; Cimino M; Di Luca M
Drug Des Deliv; 1989 Jun; 4(4):279-87. PubMed ID: 2570592
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
Seiler MP; Markstein R
Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
[No Abstract] [Full Text] [Related]
6. Synthesis of new linearly annulated tricycles as rigid dopamine congeners.
Perrone R; Berardi F; Bettoni G; Tortorella V
Farmaco Sci; 1988 Jan; 43(1):71-7. PubMed ID: 3396690
[TBL] [Abstract][Full Text] [Related]
7. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
Seiler MP; Markstein R
Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
[TBL] [Abstract][Full Text] [Related]
8. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
9. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
Hancock AA; Marsh CL
Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
[TBL] [Abstract][Full Text] [Related]
10. Link between dopamine D1 and D2 receptors in rat and human striatal tissues.
Seeman P; Tallerico T
Synapse; 2003 Mar; 47(4):250-4. PubMed ID: 12539197
[TBL] [Abstract][Full Text] [Related]
11. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
Hess EJ; Albers LJ; Le H; Creese I
J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
[TBL] [Abstract][Full Text] [Related]
13. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
McGonigle P; Boyson SJ; Reuter S; Molinoff PB
Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
[TBL] [Abstract][Full Text] [Related]
15. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
[TBL] [Abstract][Full Text] [Related]
16. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
Sonsalla PK; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the dopaminergic receptor system after chronic administration of cocaine.
Alburges ME; Narang N; Wamsley JK
Synapse; 1993 Aug; 14(4):314-23. PubMed ID: 8161369
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of a complex subunit composition of a unitary dopamine receptor: effects of lesions and proteolytic enzymes on stereospecific binding.
Leysen JE; Gommeren W; Van Gompel P
Adv Biochem Psychopharmacol; 1983; 36():147-62. PubMed ID: 6858752
[No Abstract] [Full Text] [Related]
19. Interaction of some 2-hydroxybenzylpiperidines with dopamine receptors.
Cardellini M; Claudi F; Perlini V; Balduini W; Cattabeni F; Cimino M
Farmaco Sci; 1987 Apr; 42(4):307-17. PubMed ID: 3595841
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptors and cyclic AMP in rabbit retina: a pharmacological and stereochemical analysis using semi-rigid analogs of dopamine (aminotetralins) and thioxanthene isomers.
Schorderet M; McDermed J; Magistretti P
J Physiol (Paris); 1978; 74(5):509-13. PubMed ID: 217999
[No Abstract] [Full Text] [Related]
[Next] [New Search]
